The JAMA Network will launch the new journal JAMA Oncology early next year featuring cancer-related research.
When JAMA Oncology premieres in early 2015, it will be the 11th journal in the JAMA Network, which includes the Journal of the American Medical Association (JAMA) and nine other specialty journals. All of the JAMA Oncology content–research, reviews and opinions–will be published online every Thursday and then printed in a monthly paper issue. JAMA Oncology will be the first new journal to be launched by the JAMA Network since 1999.
JAMA Oncology will address all aspects of medical, radiation and surgical oncology and its subspecialties. The journal will be a leader in the high-impact field of cancer research, where the volume of work and innovative discoveries have accelerated at a remarkable pace in an effort to keep up with the expected increase in patients diagnosed with cancer.
“JAMA Oncology presents an important new initiative for the JAMA Network—our first new journal in many years,” said Howard Bauchner, MD, editor-in-chief of JAMA and the JAMA Network. “The worldwide research effort in oncology is substantial, including lab, translational, clinical and health services research, and there are many important evolving clinical and policy issues.”
“JAMA Oncology will include original investigation, opinion (viewpoints, editorials, and invited commentaries) and clinical reviews,” Dr. Bauchner said. “And we could not be more fortunate than to have Nora Disis, MD, as our inaugural editor-in-chief. She is an internationally renowned investigator and a superb clinician.”
As the journal’s founding editor, Dr. Disis brings extensive experience to her new role. In addition to serving as a professor of medicine, she is director of the Center for Translational Medicine in Women’s Health and director of the Institute of Translational Health Sciences at the University of Washington. Dr. Disis, who specializes in breast and ovarian cancer and immunotherapy, has been deputy editor of translational oncology for the Journal of Clinical Oncology and has served on the advisory board for Science Translational Medicine.
Existing customers will have free access to JAMA Oncology in 2015. Individual physicians and other health care professionals also will be eligible to access content for free on the JAMA Network Reader. AMA members enjoy unlimited access to the JAMA Network.
